3 Things to Know Before Buying Bank of America Stock

Bank of America’s Q1 results were strong, with net revenue up 7% year over year, diluted EPS up 25%, investment banking fees up 21%, and net interest income up 9% to $15.7 billion. The bank’s deposit base remains a key advantage, with $951 billion in consumer banking deposits and 91% of checking accounts serving as primary accounts, while the stock trades at 1.5x book with consensus EPS growth of 14.6% CAGR through 2028 and a dividend yield near 2%.

Analysis

BAC is increasingly behaving like a balance-sheet compounder rather than a simple cyclical bank: the real edge is the funding franchise, which lowers deposit beta and gives management more room to defend NII if rates drift lower. That makes the stock less levered to a single macro call and more dependent on execution, especially sustaining fee growth and keeping credit costs benign. The market is implicitly paying for durability, but the premium is still modest versus the quality of the deposit moat and capital return capacity.

The second-order winner is not just BAC itself but its ability to keep pressure on smaller regionals and neobanks that lack the same primary-account stickiness. If consumer deposits keep migrating toward the largest national platforms during periods of uncertainty, funding costs should remain structurally advantaged for BAC while weaker banks are forced to pay up for liquidity or shrink balance sheets. That widens the gap in loan growth capacity and in how aggressively banks can repurchase stock.

The main risk is that current earnings momentum is being extrapolated into a softer-rate, slower-growth environment where NII can decelerate faster than consensus expects. A mild recession would not need to create a credit event to hurt the setup; even a modest rise in charge-offs or a reversal in investment banking activity could compress the multiple because the stock is trading near a performance high. The optimistic case likely plays out over quarters, not days, so the key question is whether estimates for 2026-2028 are too linear.

Consensus may be underappreciating how much of BAC’s upside is already self-financing via buybacks and dividends. At this valuation, the stock can work even without multiple expansion if EPS compounding holds, but that also means the downside is tied to any interruption in capital return cadence. The trade is less about chasing a breakout and more about owning one of the few large-cap banks with a credible path to mid-teens EPS growth if the economy avoids a hard landing.

Key Decisions for Investors

• Long BAC vs. a basket of large U.S. regionals (e.g., KRE) over the next 3-6 months: BAC benefits from deposit stickiness and better fee diversification, while regional funding pressure should persist if liquidity remains tight.
• Buy BAC on 2-3% pullbacks rather than strength-chasing; target a 6-9 month hold with upside from EPS compounding and buybacks, but use a 10-12% stop if NII guidance rolls over.
• Pair trade: long BAC / short PNC or FITB for 2-4 quarters, expressing the view that deposit franchise quality will matter more than headline valuation as funding costs remain discriminating.
• Sell out-of-the-money BAC calls 3-6 months out against a starter long if implied volatility is elevated; the near-term upside looks steadier than explosive, so premium capture improves the risk/reward.
• If macro data turns sharply weaker, reduce BAC exposure before credit headlines appear; the stock’s biggest risk is not defaults first, but multiple compression from lower NII expectations and slowing capital return cadence.